Clinical Trial Update: Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain [Phase 3]

View source ↗

Summary

Phase 3 trial comparing KW21052 to pregabalin (Lyrica) for efficacy and safety in diabetic neuropathic pain; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• KW21052
• Lyrica (Pregabalin)

Snippet

Sponsor: KunWha Pharmaceutical Co., Ltd. | Conditions: Diabetic Neuropathy | Phase 3 | Status: UNKNOWN